Role of microRNAs in development of chronic obstructive pulmonary disease

2019

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.32523/2616-7034-2019-126-1-22-30
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Chronic obstructive pulmonary disease (COPD) is a multi-pathogenesis chronic lung disease characterized by irreversible and progressive bronchial obstruction. An important role in the development of the disease belongs to the genetic predisposition and environmental factors. Although the pathogenesis of COPD is now not well understood, it is known that oxidative stress, imbalance of the proteolysis-antiproteolysis system, immune system disorders, impaired lung repair, and apoptosis dysfunction make a significant contribution to the disease. In this review, we discuss about various molecular and cellular mechanisms of COPD including airways inflammation. Special attention is paid to the role of miRNA in the development of COPD. It is considered the possibility of using microRNAs as new biomarkers and therapeutic tools for the diagnosis and treatment of COPD.